Veronica Sanchez Bulis serves as Executive at Lyell Immunopharma, Inc., where they oversee executive responsibilities. Since joining the company, Veronica Sanchez Bulis has executed 3 insider transactions totaling $9.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 10, 2026 involved selling 254 shares valued at $5.9K.
Veronica Sanchez Bulis currently holds 15,637 shares of Lyell Immunopharma, Inc. (LYEL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Veronica Sanchez Bulis has been a net seller of LYEL stock. They have purchased $0 and sold $9.7K worth of shares.
Veronica Sanchez Bulis's most recent insider trade was on Feb 10, 2026, when they sold 254 shares at $23.12 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 10, 2025 | LYEL | $3.8K | Sale | 239 | $16.10 | Discretionary |